The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Neuro-Oncology Faculty Division of Hematology, Oncology, and Blood and Marrow Transplantation
Nationwide Children's Hospital
Location: Columbus, Ohio
Type: Full Time
Hospital, Public and Private
Internal Number: 112122
The Division of Hematology, Oncology, and Blood and Marrow Transplantation in the Department of Pediatrics at The Ohio State University located at Nationwide Children’s Hospital in Columbus, Ohio is seeking a pediatric neuro-oncologist, who is Board Certified in Pediatrics and Board Certified/Eligible in Pediatric Hematology/Oncology to join our Neuro-oncology Program. Applicants must have completed pediatric neuro-oncology training. Interest in developmental therapeutics and/or immunotherapy is preferred.
The Pediatric Neuro-Oncology Program at Nationwide Children’s Hospital serves children and young adults with CNS tumors with an integrated, multi-disciplinary, and scientific approach including neurosurgery, neurology, endocrinology, neuropathology, neuroradiology, radiation oncology, physical medicine and rehabilitation, palliative care, psychosocial services, fertility preservation, genetics, survivorship, and others. In 2023, The Ohio State University in partnership with Nationwide Children’s Hospital will open the first proton treatment facility in central Ohio.
The team currently includes 4 neuro-oncologists, 4 nurse practitioners, 4 nurse navigators, 2 social workers, and other staff to support the clinical program. The Neuro-Oncology Program also offers a one-year pediatric neuro-oncology fellowship training.
The program partners closely with the Steve and Cindy Rasmussen Institute for Genomic Medicine (IGM) at Nationwide Children’s Hospital and combines a robust clinical laboratory with genome scientists and clinical geneticists to optimize patient care. NCH serves as the Biopathology Center to the Children’s Oncology Group and has 3 pediatric neuropathologists who are an integral part of multi-disciplinary clinical and research efforts of the Neuro-oncology Program. The IGM and the Biopathology Center are partnering with the National Cancer Institute and the Children’s Oncology Group in the Molecular Characterization Initiative (MCI), an NCI-funded initiative, to collect, analyze, and report clinical molecular data to support COG-affiliated clinicians in delivering targeted therapies for improved outcomes. In addition, the Neuro-Oncology Program collaborates actively with Dr. Dean Lee, Director of the Cellular Therapy and Cancer Immunotherapy Program to translate novel immunotherapy approaches to clinical trials for children with high-risk brain tumors.
This position will include clinical service and translational research. Applicants should have strong clinical skills and a commitment to teaching as well as clinical or translational research. Interest in immunotherapy and development of novel immunotherapy approaches is preferred.
Named to the Top 10 Honor Roll on U.S. News & World Report’s 2022-23 list of “Best Children’s Hospitals,” Nationwide Children’s is one of America’s largest not-for-profit free-standing pediatric health care systems. Forbes named Nationwide Children’s as one of “America’s Best Large Employers,” ranking in the top 10 among all hospitals in the United States and the No. 1 hospital in Ohio.
Nationwide Children’s has a staff of more than 13,000 that provides state-of-the-art wellness, preventive and rehabilitative care and diagnostic treatment during more than 1.3 million patient visits annually. As home to the Department of Pediatrics of The Ohio State University College of Medicine, Nationwide Children’s physicians train the next generation of pediatricians and pediatric specialists.
The Abigail Wexner Research Institute at Nationwide Children’s Hospital is one of the Top 10 National Institutes of Health-funded free-standing pediatric research facilities. More information is available at NationwideChildrens.org.
To apply, please email a cover letter and CV to:
Maryam Fouladi, MD, MSc, FRCPC
Co-Executive Director of Neuro-Oncology
Elizabeth & Richard Germain Endowed Chair in Pediatric Cancer
Division of Hematology, Oncology & Bone Marrow Transplant
Named to the Top 10 Honor Roll on U.S. News & World Report’s 2021-22 list of “Best Children’s Hospitals,” Nationwide Children’s Hospital is one of America’s largest not-for-profit free-standing pediatric health care systems providing unique expertise in pediatric population health, behavioral health, genomics and health equity as the next frontiers in pediatric medicine, leading to best outcomes for the health of the whole child. Integrated clinical and research programs, as well as prioritizing quality and safety, are part of what allows Nationwide Children’s to advance its unique model of care. Nationwide Children’s has a staff of more than 13,000 that provides state-of-the-art wellness, preventive and rehabilitative care and diagnostic treatment during more than 1.6 million patient visits annually. As home to the Department of Pediatrics of The Ohio State University College of Medicine, Nationwide Children’s physicians train the next generation of pediatricians and pediatric specialists. The Abigail Wexner Research Institute at Nationwide Children’s Hospital is one of the Top 10 National Institutes of Health-funded free-standing pediatric research facilities. More information is... available at NationwideChildrens.org. The Research Institute at Nationwide Children’s is ranked in the top 10 nationally in NIH funding to free-standing children’s hospitals. Research programs are organized into 12 multidisciplinary Centers of Emphasis structured to encourage collaboration, facilitate team science and foster creativity.